- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Immuno-Biological Laboratories Co Ltd (4570)
Immuno-Biological Laboratories Co Ltd stock price live, this page displays TYO 4570 stock exchange data. View the 4570 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Immuno-Biological Laboratories Co Ltd real time stock price chart below.
What Is the Immuno-Biological Laboratories Co Ltd Stock Price Today?
The Immuno-Biological Laboratories Co Ltd stock price today is 479.0.
What Is the Stock Symbol for Immuno-Biological Laboratories Co Ltd?
The stock symbol for Immuno-Biological Laboratories Co Ltd is ""4570.""
What Stock Exchange Does Immuno-Biological Laboratories Co Ltd Trade On?
Immuno-Biological Laboratories Co Ltd is listed and trades on the Tokyo stock exchange.
Is Immuno-Biological Laboratories Co Ltd a Good Stock to Buy?
Determining whether Immuno-Biological Laboratories Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4570 quote. (ISIN: JP3921300004)
What Is the Immuno-Biological Laboratories Co Ltd Stock Price Today?
The Immuno-Biological Laboratories Co Ltd stock price today is 479.0.
What Is the Stock Symbol for Immuno-Biological Laboratories Co Ltd?
The stock symbol for Immuno-Biological Laboratories Co Ltd is ""4570.""
What Stock Exchange Does Immuno-Biological Laboratories Co Ltd Trade On?
Immuno-Biological Laboratories Co Ltd is listed and trades on the Tokyo stock exchange.
Is Immuno-Biological Laboratories Co Ltd a Good Stock to Buy?
Determining whether Immuno-Biological Laboratories Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4570 quote. (ISIN: JP3921300004)
Tokyo
Currency in JPY
479.0
+4.0(+0.84%)
Closed·
Fair Value
An estimate of a Immuno-Biological Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
477.0
480.0
52 wk Range
356.0
603.0
4570 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4570 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Immuno-Biological Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
477.0480.0
52 wk Range
356.0603.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4570 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Immuno-Biological Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Immuno-Biological Laboratories Co Ltd Company Profile
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer’s disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Compare 4570 to Peers and Sector
Metrics to compare | 4570 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4570PeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.1x | −1.9x | −0.6x | |
PEG Ratio | 1.22 | 0.01 | 0.00 | |
Price/Book | 2.8x | 1.4x | 2.6x | |
Price / LTM Sales | 4.7x | 1.5x | 3.3x | |
Upside (Analyst Target) | - | 64.5% | 38.7% | |
Fair Value Upside | Unlock | 15.2% | 5.1% | Unlock |
Earnings
Latest Release
Aug 08, 2025
EPS / Forecast
6.54 / --
Revenue / Forecast
211.00M / --
FAQ
What Stock Exchange Does Immuno-Biological Laboratories Trade On?
Immuno-Biological Laboratories is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Immuno-Biological Laboratories?
The stock symbol for Immuno-Biological Laboratories is "4570."
What Is the Immuno-Biological Laboratories Market Cap?
As of today, Immuno-Biological Laboratories market cap is 4.47B.
What Is Immuno-Biological Laboratories's Earnings Per Share (TTM)?
The Immuno-Biological Laboratories EPS (TTM) is 27.70.
When Is the Next Immuno-Biological Laboratories Earnings Date?
Immuno-Biological Laboratories will release its next earnings report on 30 Oct 2025.
From a Technical Analysis Perspective, Is 4570 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Immuno-Biological Laboratories Stock Split?
Immuno-Biological Laboratories has split 1 times.
How Many Employees Does Immuno-Biological Laboratories Have?
Immuno-Biological Laboratories has 58 employees.
What is the current trading status of Immuno-Biological Laboratories (4570)?
As of 28 Aug 2025, Immuno-Biological Laboratories (4570) is trading at a price of 479.0, with a previous close of 475.00. The stock has fluctuated within a day range of 477.0 to 480.0, while its 52-week range spans from 356.0 to 603.0.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.